Inventor · Haverhill, GB

Philip R. Tempest

19Patents
11h-index
23Co-inventors
68Inventor score

Filing activity: May 4, 1995 → Sep 27, 2010

Most-cited inventions

PatentTitleAreaCited byStatus
US6602503B1 Recombinant anti-VLA-4 antibody molecules Chemistry; Metallurgy 71 Expired
US7829092B2 Recombinant anti-VLA4 antibody molecules Chemistry; Metallurgy 53 Active
US8226950B2 Recombinant anti-VLA4 antibody molecules Chemistry; Metallurgy 49 Active
US6492497B1 Specific binding members for TGFbeta1 Chemistry; Metallurgy 46 Expired
US7151169B2 Specific binding members for TGFβ1 Chemistry; Metallurgy 40 Expired
US6417337B1 High affinity humanized anti-CEA monoclonal antibodies Chemistry; Metallurgy 22 Expired
US7368111B2 Human antibodies specific for TGFβ2 Chemistry; Metallurgy 17 Expired
US6348581B1 High affinity humanized anti-TAG-72 monoclonalantibodies Chemistry; Metallurgy 13 Expired
US7157086B2 Treatment for inflammatory bowel disease with α4-specific antibodies Chemistry; Metallurgy 12 Expired
US6333405A High affinity humanized anti-CEA monoclonal antibodies Chemistry; Metallurgy 11 Expired
US6500931B1 Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes Chemistry; Metallurgy 11 Expired
US6827925B1 Specific binding proteins including antibodies which bind to the necrotic center of tumors, and uses thereof Emerging Cross-Sectional Technologies 8 Expired
US7482003B2 Treatment for asthma with α4-specific antibodies Chemistry; Metallurgy 6 Active
US6753420B2 High affinity humanized anti-Tag-72 monoclonal antibodies Chemistry; Metallurgy 1 Expired
US6737061B2 High affinity humanized anti-TAG-72 monoclonal antibodies Chemistry; Metallurgy 0 Expired
US6752990B2 High affinity humanized anti-TAG-72 monoclonal antibodies Chemistry; Metallurgy 0 Expired
US6753152B2 High affinity humanized anti-tag-72 monoclonalantibodies Chemistry; Metallurgy 0 Expired
US6737060B2 High affinity humanized anti-TAG-72 monoclonal antibodies Chemistry; Metallurgy 0 Expired
US7605234B2 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.